搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
20 小时
DripDrop® Hydration Launches New Sunburst Variety Pack Exclusively at Walmart
DripDrop® Hydration, a leading electrolyte powder brand, has launched Sunburst Variety Pack, a new 8ct variety pack with new ...
3 小时
on MSN
Patanjali pan flavour toothpaste: Traditional twist for fresh, herbal smiles
Patanjali introduces its Pan Flavour Toothpaste, blending traditional taste with natural ingredients for effective, refreshing oral care.
Business Wire
1 小时
CN Bio Launches PhysioMimix Bioavailability Assay Kit: Human 18
CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, ...
22 小时
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
For more information on Cardiol Therapeutics and the PRISM Emerging Biotech Index, visit prismmarketview.com.
AdnKronos
2 小时
Mallinckrodt announces the 2024 Winner of the Extracorporeal Immunomodulation Award
Consult the 8-methoxypsoralen (Methoxsalen (20 micrograms / mL)) professional leaflet or the oral 8-methoxypsoralen formulation package insert before prescribing or dispensing any medication. Warnings ...
Nanowerk
20 小时
Self-navigating nanoparticles advance inflammatory bowel disease treatment
Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.
14 小时
Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business ...
Generated $48.1 million in XDEMVY® net product sales driven by more than 41,400 bottles delivered to patients in the third quarterStrengthened ...
Concord Monitor
18 小时
Supreme Court hears arguments in school funding case
The justices questioned the appropriate solution in the event that they hold the SWEPT tax system unconstitutional ... That ...
Stockhead on MSN
9 小时
Health Check: Actinogen powers ahead with key Alzheimer’s disease trial
Actinogen reports its advanced Alzheimer's disease trial is recruiting strongly, with first results expected by mid next year ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈